Skip to content

Exploring the effect of dexmedetomidine on postoperative delirium in elderly orthopedic patients from the perspective of intestinal flora: a randomized controlled trial

Exploring the effect of dexmedetomidine on postoperative delirium in elderly orthopedic patients from the perspective of intestinal flora: a randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072970
Enrollment
Unknown
Registered
2023-06-29
Start date
2023-06-30
Completion date
Unknown
Last updated
2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orthopedic surgery postoperative delirium

Interventions

Group 1:Give dexmedetomidine a fixed load of 0.5 µg/kg, intraoperative infusion rate 0.5 µg/kg·h
Group 2:Intraoperative infusion of physiological saline

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: Age 60-80 ASA < Grade IV Planned to undergo unilateral total hip/knee replacement under general anesthesia

Exclusion criteria

Exclusion criteria: Communication barriers Patients with preoperative cognitive impairment measured by the Concise Mental Rating Scale Severe arrhythmia, heart failure, acute coronary syndrome, severe liver and renal dysfunction History of gastrointestinal surgery, inflammatory bowel disease, irritable bowel syndrome, gastroenteritis, constipation, gastrointestinal ulcers, gastrointestinal bleeding, diarrhea, use of salicylic acid preparations

Design outcomes

Primary

MeasureTime frame
Incidence of delirium within 5 days after surgery;

Secondary

MeasureTime frame
Sample species composition and community structure;Duration and severity of delirium;Postoperative MMSE score, anxiety score, and pain score (days 1-5);

Countries

China

Contacts

Public ContactSu Liu

The Affiliated Hospital of Xuzhou Medical University

150040009@qq.com+86 181 1830 9692

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026